Amidst Industry Challenges, 85% of Pharmas Increase Investment in AI

A new report found that 85% of pharma respondents are increasing their artificial intelligence investments, and 70% see AI as an immediate priority. Two experts discuss how biopharmas are implementing and adopting AI, including their increased use of external help with the process.

Biopharma industry challenges and budget cuts don’t appear to be affecting artificial intelligence (AI) investment, implementation and adoption. For example, according to venture capital firm Define Ventures’ new report about AI deployment at pharmas, 40% of respondents are significantly increasing and 45% somewhat increasing their artificial intelligence investments even as overall budgets contract.

Keep reading at BioSpace: https://www.biospace.com/job-trends/amidst-industry-challenges-85-of-pharmas-increase-investment-in-ai?